Potentiation of coxsackievirus B3 infection in adult mice pretreated with a gold salt
- 1 January 1978
- journal article
- research article
- Published by Wiley in Journal of Medical Virology
- Vol. 3 (2) , 125-136
- https://doi.org/10.1002/jmv.1890030206
Abstract
In mice treated with sodium aurothiomalate (myocrisin), prior to infection with Coxsackievirus B3, 90% of the animals died by the 11 th day postinfection (p.i.) A mortality of 10% was noted in mice receiving myocrisin only, and no deaths occurred in animals infected with virus alone. The highest amount of virus was recovered from the pancreas of myocrisin-treated mice on day 3 p.i. This was over 500-fold higher than the virus titer found in the pancreas of mice infected with virus only. Generally the titer of virus present in different organs was higher at every point in drug-treated animals as compared to intact mice infected with the virus. A high and persistent viremia was present in myocrisin-treated mice; in contrast a low viremia followed by virus clearance from the blood was observed in intact mice infected with the virus. The antibody response was studied in intact and myocrisin-treated mice infected with the virus. In both groups, no neutralizing antibodies were detected on days 1, 2, and 3 p.i. On day 7 after infection, the titers of antibodies were 1:16 and 1:12 in intact and myocrisin-treated mice, respectively. Administration of hyperimmune anti-Coxsackievirus B3 serum 6 hours after infection protrected the myocrisin-treated group of mice against lethal disease. The results of these studies suggest that (1) antibodies alone may not be sufficient to limit the spread and persistence of virus in natural infections and (2) in the absence of any apparent histopathological differences the increased multiplication of Coxsackievirus B3 could be the cause of death in myocrisintreated mice.Keywords
This publication has 15 references indexed in Scilit:
- Susceptibility of mice to group B coxsackie virus is influenced by the diabetic gene.The Journal of Experimental Medicine, 1976
- Immunomodification and the Expression of Virulence in Mice by Defined Strains of Semliki Forest Virus: the Effects of Myocrisin and l-AsparaginaseJournal of General Virology, 1975
- Peroral Infection with Group B Coxsackievims in the Adult Mouse: Protective Functions of the GutThe Journal of Infectious Diseases, 1974
- Modifications by Sodium auro-thio-malate of the expression of Virulence in Mice by defined strains of Semliki Forest VirusJournal of General Virology, 1974
- Effects of Immunosuppression on Coxsackie B-3 Virus Infection in Mice, and Passive Protection by Circulating AntibodyJournal of General Virology, 1973
- The Role of Antibody and Host Cells in the Resistance of Mice Against Infection by Coxsackie B-3 VirusJournal of General Virology, 1973
- A Controlled Trial of Gold Salt Therapy in Rheumatoid ArthritisArthritis & Rheumatism, 1973
- Immunoresponsiveness of patients with rheumatoid arthritis receiving cyclophosphamide or gold salts.Annals of the Rheumatic Diseases, 1973
- Coxsackie virus infections: Clinical and laboratory studiesThe Journal of Pediatrics, 1964
- SUSCEPTIBILITY OF GRAVID MICE TO COXSACKIE VIRUS INFECTIONThe Journal of Experimental Medicine, 1954